| 000 | 01820 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514020520.0 | ||
| 264 | 0 | _c20020320 | |
| 008 | 200203s 0 0 eng d | ||
| 022 | _a0195-668X | ||
| 024 | 7 |
_a10.1053/euhj.2001.2695 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJanzon, M | |
| 245 | 0 | 0 |
_aCost-effectiveness of an invasive strategy in unstable coronary artery disease; results from the FRISC II invasive trial. The Fast Revascularisation during InStability in Coronary artery disease. _h[electronic resource] |
| 260 |
_bEuropean heart journal _cJan 2002 |
||
| 300 |
_a31-40 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAmbulatory Care _xeconomics |
| 650 | 0 | 4 |
_aCoronary Artery Disease _xcomplications |
| 650 | 0 | 4 |
_aCost-Benefit Analysis _xeconomics |
| 650 | 0 | 4 |
_aElectrocardiography _xeconomics |
| 650 | 0 | 4 | _aEndpoint Determination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibrinolytic Agents _xeconomics |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHealth Care Costs |
| 650 | 0 | 4 |
_aHospitalization _xeconomics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMyocardial Infarction _xcomplications |
| 650 | 0 | 4 |
_aPlatelet Glycoprotein GPIIb-IIIa Complex _xeconomics |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aScandinavian and Nordic Countries _xepidemiology |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 |
_aVentricular Function, Left _xphysiology |
| 700 | 1 | _aLevin, L A | |
| 700 | 1 | _aSwahn, E | |
| 773 | 0 |
_tEuropean heart journal _gvol. 23 _gno. 1 _gp. 31-40 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1053/euhj.2001.2695 _zAvailable from publisher's website |
| 999 |
_c11654579 _d11654579 |
||